Search results
Results from the WOW.Com Content Network
341,831 (2020) [11] Cervical cancer is a cancer arising from the cervix or in any layer of the wall of the cervix. [2] It is due to the abnormal growth of cells that have the ability to invade or spread to other parts of the body. [12] Early on, typically no symptoms are seen. [2] Later symptoms may include abnormal vaginal bleeding, pelvic ...
Pelvic exenteration (or pelvic evisceration) is a radical surgical treatment that removes all organs from a person's pelvic cavity. It is used to treat certain advanced or recurrent cancers. The urinary bladder, urethra, rectum, and anus are removed. In women, the vagina, cervix, uterus, Fallopian tubes, ovaries and, in some cases, the vulva ...
Uterine artery embolization (UAE, uterine fibroid embolization, or UFE) is a procedure in which an interventional radiologist uses a catheter to deliver small particles that block the blood supply to the uterine body. The procedure is primarily done for the treatment of uterine fibroids and adenomyosis.
Magnetic resonance neurography. Magnetic resonance neurography (MRN) is the direct imaging of nerves in the body by optimizing selectivity for unique MRI water properties of nerves. It is a modification of magnetic resonance imaging. This technique yields a detailed image of a nerve from the resonance signal that arises from in the nerve itself ...
Uterine sarcoma. The uterine sarcomas form a group of malignant tumors that arises from the smooth muscle or connective tissue of the uterus. They can be difficult to detect, as symptoms are common to other uterine conditions and no specific screening test has been developed. This presents an issue for treatment, as the cancer spreads quickly.
Wertheim–Meigs operation. Cutting of the peritoneum to separate the uterus from the abdominal wall. The Wertheim–Meigs operation (named after Ernst Wertheim and Joe Vincent Meigs) is a surgical procedure for the treatment of cervical cancer performed by way of an abdominal incision.
As many as 16% of those treated with the chemotherapeutic cyclophosphamide go on to develop bladder cancer within 15 years of their treatment. [69] Similarly, those treated with pelvic radiation (typically for prostate or cervical cancer) are at increased risk of developing bladder cancer five to 15 years after treatment. [69]
Studies in people having pelvic radiotherapy as part of anticancer treatment for a primary pelvic cancer found that changes in dietary fat, fibre and lactose during radiotherapy reduced diarrhoea at the end of treatment. [25] Swelling As part of the general inflammation that occurs, swelling of soft tissues may cause problems during radiation ...